In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Acacia Research Corp (NASDAQ: ACTG) was $3.26 for the day, down -9.19% from the previous closing price of $3.59. In other words, the price has decreased by -$9.19 from its previous closing price. On the day, 0.72 million shares were traded. ACTG stock price reached its highest trading level at $3.69 during the session, while it also had its lowest trading level at $3.145.
Ratios:
Our analysis of ACTG’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.29 and its Current Ratio is at 8.80. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on May 22, 2020, initiated with a Buy rating and assigned the stock a target price of $4.
On July 29, 2016, Barclays reiterated its Underweight rating and also lowered its target price recommendation from $4 to $6.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 11 ’25 when Kohlberg Isaac T. sold 16,000 shares for $3.84 per share. The transaction valued at 61,440 led to the insider holds 85,446 shares of the business.
Kohlberg Isaac T. bought 16,000 shares of ACTG for $61,440 on Jun 11 ’25. On May 21 ’25, another insider, Soncini Jason W., who serves as the General Counsel of the company, bought 7,000 shares for $3.79 each. As a result, the insider paid 26,523 and bolstered with 209,184 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACTG now has a Market Capitalization of 313519744 and an Enterprise Value of 172991408. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.27 while its Price-to-Book (P/B) ratio in mrq is 0.46. Its current Enterprise Value per Revenue stands at 0.778 whereas that against EBITDA is 3.32.
Stock Price History:
The Beta on a monthly basis for ACTG is 0.66, which has changed by -0.33739835 over the last 52 weeks, in comparison to a change of 0.19283521 over the same period for the S&P500. Over the past 52 weeks, ACTG has reached a high of $5.36, while it has fallen to a 52-week low of $2.70. The 50-Day Moving Average of the stock is -12.11%, while the 200-Day Moving Average is calculated to be -17.52%.
Shares Statistics:
ACTG traded an average of 208.98K shares per day over the past three months and 209850 shares per day over the past ten days. A total of 96.17M shares are outstanding, with a floating share count of 94.45M. Insiders hold about 1.79% of the company’s shares, while institutions hold 87.13% stake in the company. Shares short for ACTG as of 1752537600 were 1346505 with a Short Ratio of 6.44, compared to 1749772800 on 1354425. Therefore, it implies a Short% of Shares Outstanding of 1346505 and a Short% of Float of 3.9600000000000004.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current rating of Acacia Research Corp (ACTG) reflects the combined expertise of 1.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.14 and low estimates of -$0.14.
Analysts are recommending an EPS of between -$0.09 and -$0.09 for the fiscal current year, implying an average EPS of -$0.09. EPS for the following year is -$0.53, with 1.0 analysts recommending between -$0.53 and -$0.53.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 1 analysts. It ranges from a high estimate of $38M to a low estimate of $38M. As of the current estimate, Acacia Research Corp’s year-ago sales were $23.31MFor the next quarter, 1 analysts are estimating revenue of $38M. There is a high estimate of $38M for the next quarter, whereas the lowest estimate is $38M.
A total of 1 analysts have provided revenue estimates for ACTG’s current fiscal year. The highest revenue estimate was $251.66M, while the lowest revenue estimate was $251.66M, resulting in an average revenue estimate of $251.66M. In the same quarter a year ago, actual revenue was $122.31MBased on 1 analysts’ estimates, the company’s revenue will be $170M in the next fiscal year. The high estimate is $170M and the low estimate is $170M.
